Teriparatide and denosumab: two drugs are better than one!

Buckland, Jenny

doi:10.1038/nrrheum.2013.79

Cited by 1 publication

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 181 Nevertheless, the combination of denosumab and teriparatide improved BMD at the spine and hip more than with either denosumab or teriparatide alone in patients with severe OP. 182 , 183 Further research is still needed to determine whether these combinations result in improved fracture protection, and their long-term safety implications should be considered.…”

Section: Management Of Opmentioning

confidence: 99%

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives

Lin¹,

Xiong²,

Peng³

et al. 2015

CIA

122

View full text Add to dashboard Cite

With the progressive aging of the population, osteoporosis has gradually grown into a global health problem for men and women aged 50 years and older because of its consequences in terms of disabilities and fragility fractures. This is especially true in the People’s Republic of China, which has the largest population and an increasing proportion of elderly people, as osteoporosis has become a serious challenge to the Chinese government, society, and family. Apart from the fact that all osteoporotic fractures can increase the patient’s morbidity, they can also result in fractures of the hip and vertebrae, which are associated with a significantly higher mortality. The cost of osteoporotic fractures, moreover, is a heavy burden on families, society, and even the country, which is likely to increase in the future due, in part, to the improvement in average life expectancy. Therefore, understanding the epidemiology of osteoporosis is essential and is significant for developing strategies to help reduce this problem. In this review, we will summarize the epidemiology of osteoporosis in the People’s Republic of China, including the epidemiology of osteoporotic fractures, focusing on preventive methods and the management of osteoporosis, which consist of basic measures and pharmacological treatments.

show abstract

Section: Management Of Opmentioning

confidence: 99%

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives

Lin¹,

Xiong²,

Peng³

et al. 2015

CIA

122

View full text Add to dashboard Cite

show abstract

Teriparatide and denosumab: two drugs are better than one!

Cited by 1 publication

References 1 publication

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives

Contact Info

Product

Resources

About

Teriparatide and denosumab: two drugs are better than one!

Cited by 1 publication

References 1 publication

Epidemiology and management of osteoporosis in the People&rsquo;s Republic of China: current perspectives

Epidemiology and management of osteoporosis in the People&rsquo;s Republic of China: current perspectives

Contact Info

Product

Resources

About

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives